Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Thyroid Cancer and Central Lymph Node Metastases Using EMI-137 Enhanced Molecular Fluorescent Guided Imaging: a Multicentre Feasibility and

NCT03470259 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT03470259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03470259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Thyroid Cancer and Central Lymph Node Metastases Using EMI-137 Enhanced Molecular Fluorescent Guided Imaging: a Multicentre Feasibility and
Lead sponsor
University Medical Center Groningen
Phase
Phase 1
Overall status
Completed
Start date
June 20, 2018
Completion date
December 31, 2019
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastases, papillary thyroid cancer